dimethadione has been researched along with Carcinoma, Hepatocellular in 1 studies
Dimethadione: An anticonvulsant that is the active metabolite of TRIMETHADIONE.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, E | 1 |
| Ishikawa, A | 1 |
| Ono, A | 1 |
| Okamura, T | 1 |
| Misawa, S | 1 |
1 other study available for dimethadione and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
Topics: Carcinoma, Hepatocellular; Chronic Disease; Dimethadione; Female; Humans; Liver Cirrhosis; Liver Dis | 1987 |